Microenvironmental Enzyme-Responsive Methotrexate Modified Quercetin Micelles for the Treatment of Rheumatoid Arthritis

References

• McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 2017;389(10086):2328–2337. doi:10.1016/S0140-6736(17)31472-1
   PubMed Web of Science ®Google Scholar
• Mateen S, Zafar A, Moin S, Khan AQ, Zubair S. Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis. Clin Chim Acta. 2016;455:161–171. doi:10.1016/j.cca.2016.02.010
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–2038. doi:10.1016/S0140-6736(16)30173-8
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang Y, Pan J. Immunopathogenic mechanisms of rheumatoid arthritis and the use of anti-inflammatory drugs. Intractable Rare Dis Res. 2021;10(3):154–164. doi:10.5582/irdr.2021.01022
   PubMed Web of Science ®Google Scholar
• Tardito S, Martinelli G, Soldano S, et al. Macrophage M1/M2 polarization and rheumatoid arthritis: a systematic review. Autoimmun Rev. 2019;18(11):102397. doi:10.1016/j.autrev.2019.102397
   PubMed Web of Science ®Google Scholar
• Zheng X, Yu X, Wang C, et al. Targeted co-delivery biomimetic nanoparticles reverse macrophage polarization for enhanced rheumatoid arthritis therapy. Drug Deliv. 2022;29(1):1025–1037. doi:10.1080/10717544.2022.2057616
   PubMed Web of Science ®Google Scholar
• Boutet MA, Courties G, Nerviani A, et al. Novel insights into macrophage diversity in rheumatoid arthritis synovium. Autoimmun Rev. 2021;20(3):102758. doi:10.1016/j.autrev.2021.102758
   PubMed Web of Science ®Google Scholar
• Liu W, Zhang Y, Zhu W, et al. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets. Front Immunol. 2018;9:2228. doi:10.3389/fimmu.2018.02228
   PubMed Web of Science ®Google Scholar
• Goyal A, Agrawal N. Quercetin: a Potential Candidate for the Treatment of Arthritis. Curr Mol Med. 2022;22(4):325–335. doi:10.2174/1566524021666210315125330
   PubMed Web of Science ®Google Scholar
• Shen P, Lin W, Deng X, et al. Potential Implications of Quercetin in Autoimmune Diseases. Front Immunol. 2021;12:689044. doi:10.3389/fimmu.2021.689044
   PubMed Web of Science ®Google Scholar
• Kumazawa Y, Kawaguchi K, Takimoto H. Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha. Curr Pharm Des. 2006;12(32):4271–4279. doi:10.2174/138161206778743565
   PubMed Web of Science ®Google Scholar
• Tang M, Zeng Y, Peng W, et al. Pharmacological Aspects of Natural Quercetin in Rheumatoid Arthritis. Drug Des Devel Ther. 2022;16:2043–2053. doi:10.2147/DDDT.S364759
   PubMed Web of Science ®Google Scholar
• Gokhale JP, Mahajan HS, Surana SJ. Quercetin loaded nanoemulsion-based gel for rheumatoid arthritis: in vivo and in vitro studies. Biomed Pharmacother. 2019;112:108622. doi:10.1016/j.biopha.2019.108622
   PubMed Web of Science ®Google Scholar
• Wang K, Yin C, Ye X, et al. A Metabolic Driven Bio-Responsive Hydrogel Loading Psoralen for Therapy of Rheumatoid Arthritis. Small. 2023;19(21):e2207319. doi:10.1002/smll.202207319
   PubMed Web of Science ®Google Scholar
• Canavan M, Marzaioli V, McGarry T, et al. Rheumatoid arthritis synovial microenvironment induces metabolic and functional adaptations in dendritic cells. Clin Exp Immunol. 2020;202(2):226–238. doi:10.1111/cei.13479
   PubMed Web of Science ®Google Scholar
• Nakashima-Matsushita N, Homma T, Yu S, et al. Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheum. 1999;42(8):1609–1616. doi:10.1002/1529-0131(199908)42:8
   PubMed Web of Science ®Google Scholar
• Nogueira E, Sárria MP, Azoia NG, et al. Internalization of Methotrexate Conjugates by Folate Receptor-α. Biochemistry. 2018;57(49):6780–6786. doi:10.1021/acs.biochem.8b00607
   PubMed Web of Science ®Google Scholar
• Angulo-Pachón CA, Pozo V, Miravet JF. Alkaline cations dramatically control molecular hydrogelation by an amino acid-derived anionic amphiphile. J Colloid Interface Sci. 2023;635:524–534. doi:10.1016/j.jcis.2022.12.134
   PubMed Web of Science ®Google Scholar
• Palsson-McDermott EM. Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the warburg effect in LPS-activated macrophages. Cell Metab. 2015;21(1):65–80. doi:10.1016/j.cmet.2014.12.005
   PubMed Web of Science ®Google Scholar
• Yao Q, Liu Y, Kou L, Tu Y, Tang X, Zhu L. Tumor-targeted drug delivery and sensitization by MMP2-responsive polymeric micelles. Nanomedicine. 2019;19:71–80. doi:10.1016/j.nano.2019.03.012
   PubMed Web of Science ®Google Scholar
• Dai Z, Tu Y, Zhu L. Multifunctional Micellar Nanocarriers for Tumor-Targeted Delivery of Hydrophobic Drugs. J Biomed Nanotechnol. 2016;12(6):1199–1210. doi:10.1166/jbn.2016.2249
   PubMed Web of Science ®Google Scholar
• Zhang X, Xu X, Chen J, et al. Identification of HHT-9041P1: a novel potent and selective JAK1 inhibitor in a rat model of rheumatoid arthritis. Int Immunopharmacol. 2023;125(Pt A):111086. doi:10.1016/j.intimp.2023.111086
   PubMedGoogle Scholar
• Yu C, Liu H, Guo C, et al. Dextran sulfate-based MMP-2 enzyme-sensitive SR-A receptor targeting nanomicelles for the treatment of rheumatoid arthritis. Drug Deliv. 2022;29(1):454–465. doi:10.1080/10717544.2022.2032482
   PubMed Web of Science ®Google Scholar
• Guo RB, Zhang XY, Yan DK, et al. Folate-modified triptolide liposomes target activated macrophages for safe rheumatoid arthritis therapy. Biomater Sci. 2022;10(2):499–513. doi:10.1039/d1bm01520f
   PubMed Web of Science ®Google Scholar
• Zhu W, Song Z, Wei P, et al. Y-shaped biotin-conjugated poly (ethylene glycol)-poly (epsilon-caprolactone) copolymer for the targeted delivery of curcumin. J Colloid Interface Sci. 2015;443:1–7. doi:10.1016/j.jcis.2014.11.073
   PubMed Web of Science ®Google Scholar
• Liu Y, Xie B, Li L, et al. PEGylated lipid microspheres loaded with cabazitaxel for intravenous administration: stability, bioavailability, antitumor efficacy, and toxicity. Drug Deliv Transl Res. 2018;8(5):1365–1379. doi:10.1007/s13346-018-0562-0
   PubMed Web of Science ®Google Scholar
• Yang S, Zhao M, Jia S. Macrophage: key player in the pathogenesis of autoimmune diseases. Front Immunol. 2023;14:1080310. doi:10.3389/fimmu.2023.1080310
   PubMedGoogle Scholar
• Song Y, Gao N, Yang Z, et al. Characteristics, polarization and targeted therapy of mononuclear macrophages in rheumatoid arthritis. Am J Transl Res. 2023;15(3):2109–2121.
   PubMed Web of Science ®Google Scholar
• Kong JS, Jeong GH, Yoo SA. The use of animal models in rheumatoid arthritis research. J Yeungnam Med Sci. 2023;40(1):23–29. doi:10.12701/jyms.2022.00773
   PubMedGoogle Scholar
• Jia N, Gao Y, Li M, et al. Metabolic reprogramming of proinflammatory macrophages by target delivered roburic acid effectively ameliorates rheumatoid arthritis symptoms. Signal Transduct Target Ther. 2023;8(1):280. doi:10.1038/s41392-023-01499-0
   PubMed Web of Science ®Google Scholar
• Li Y, Liang Q, Zhou L, et al. An ROS-responsive artesunate prodrug nanosystem co-delivers dexamethasone for rheumatoid arthritis treatment through the HIF-1α/NF-κB cascade regulation of ROS scavenging and macrophage repolarization. Acta Biomater. 2022;152:406–424. doi:10.1016/j.actbio.2022.08.054
   PubMed Web of Science ®Google Scholar